BioSpace News Archive

The world’s leading experts in Parkinson’s disease and Movement Disorders will present the latest research findings and state-of-the-art treatment options at the International Parkinson and Movement Disorder Society’s (MDS) International Congress of Parkinson’s Disease and Movement Disorders® in Hong Kong, October 5-9, 2018.

ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today announced additional positive Phase 3 data from the IMPLANT 2 trial of its oral, oxytocin receptor antagonist, Nolasiban in patients undergoing IVF procedures, as well as future development plans following receipt of EU regulatory feedback.

Dr. Vivian Ho named as first recipient of new award honoring innovative healthcare professionals who protect the public health of their community

CMOs hit by reduced volumes of opioid manufacturing from DEA quota changes, but Cannabis sales to ignite

HighTide Therapeutics Inc. participated in the 2nd Annual Pediatric Autoimmune Liver Disease Symposium and Family Day at Cincinnati Children’s Hospital Medical Center (CCHMC), September 29-30, 2018.

A new cancer treatment offered at MemorialCare Long Beach Medical Center is helping to protect patients’ hearts from the effects of radiation therapy.

Brings Pinnacle Treatment Center Network to 25 Statewide Locations

Informa Exhibitions has named Daily Advantage by Dr. David Williams and Omega-3 SLIM Max by Dr. Stephen Sinatra as two of its finalists for the 2018 SupplySide CPG Editor’s Choice Awards.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced it has commenced an underwritten public offering of 2.5 million shares of its common stock pursuant to its existing shelf registration statement.

BD (Becton, Dickinson and Company) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2018 earnings conference call on Tuesday, November 6, 2018, at 8:00 a.m. (ET).